NYC becoming hotter for life science startups
Merck gets fourth lung cancer approval for Keytruda in Europe
CEO of Novartis generics quits, sparking sale speculation
Will Insys be able to survive?
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*